Cue Biopharma, Inc.
CUE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$40,674 | -$50,733 | -$53,010 | -$44,161 |
| Dep. & Amort. | $2,350 | $3,436 | $1,806 | -$1,778 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6,846 | $8,180 | $9,496 | $11,516 |
| Change in WC | -$4,925 | -$934 | $356 | -$4,387 |
| Other Non-Cash | $74 | $90 | -$454 | -$26 |
| Operating Cash Flow | -$36,329 | -$39,961 | -$41,806 | -$38,837 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$66 | $0 | -$171 | -$913 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$29,445 | $0 |
| Inv. Sales/Matur. | $0 | $25,000 | $5,000 | $10,000 |
| Other Inv. Act. | $98 | $2 | $6 | $22 |
| Investing Cash Flow | $32 | $25,002 | -$24,610 | $9,109 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3,999 | -$2,000 | $10,000 | $0 |
| Stock Issued | $14,224 | $13,387 | $39,300 | $17,385 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $18 | $473 | $4,359 | $1,849 |
| Financing Cash Flow | $10,243 | $11,860 | $53,659 | $19,233 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$26,054 | -$3,099 | -$12,757 | -$10,495 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $48,665 | $51,764 | $64,521 | $75,016 |
| End Cash | $22,611 | $48,665 | $51,764 | $64,521 |
| Free Cash Flow | -$36,395 | -$39,961 | -$41,977 | -$39,750 |